Drug
Ravpal Peg
Ravpal Peg: highest development phase Phase 1, developed by BioMarin Pharmaceutical. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- BioMarin Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| rAvPAL-PEG NCT00634660 | Phase 1 | Phenylketonuria |
Latest
No recent events.
Follow Ravpal Peg on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.